Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. PharmaKon Pharmaceuticals
483
•PharmaKon Pharmaceuticals•April 8, 2014

PharmaKon Pharmaceuticals – FDA 483, Apr 8, 2014

Record Details

The FDA Form 483 documents observations from an inspection, indicating a failure to follow written production and process control procedures.

**Key Observations:**

* **Recall Procedures Not Followed:** Recall Procedures SOP PL 122 states QA is responsible for issuing recalls. However, Incident Report 001, dated March 26, 2014, noted mislabeling of NDC 45183-001-05 (Midazolam) with an incorrect concentration (0.1mg/mL instead of 0.2mg/mL), but no recall was issued. The labels for Midazolam lots E0433735C and E1016227C incorrectly stated "Midazolam 0.2mg/2mL 0.9% Sodium Chloride Total dosage: 0.4 mg per 2mL." * **Labeling System Deficiencies:** Labeling: Printing and Issuance SOP PH127 requires label templates to be on a specific system accessible only by authorized personnel, with labels printed and verified by a manager or QA. The system used for storing templates and printing labels lacks an audit trail, security access, user role permissions, or user controls to ensure only authorized personnel can access template files. * **Unauthorized Label Template Change and Lack of Verification:** The label template for Midazolam 0.2mg/2mL in

Company
PharmaKon Pharmaceuticals
Inspection date
April 8, 2014
Product type
Drugs
Office
Detroit District Office
Person
  • Meisha R. Waters (Investigator)
View Company Profile

ID · 9035aec7-848b-45d5-bbb2-68c42370f06f

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for PharmaKon Pharmaceuticals
  • WARNING_LETTER - 2014-04-08April 8, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PharmaKon Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.